Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-13-014337
Filing Date
2013-11-12
Accepted
2013-11-08 17:37:44
Documents
9
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q bota20130930_10q.htm 10-Q 554215
2 EXHIBIT 31.1 ex31-1.htm EX-31 17561
3 EXHIBIT 32.1 ex32-1.htm EX-32 7001
  Complete submission text file 0001437749-13-014337.txt   2553624

Data Files

Seq Description Document Type Size
4 EXHIBIT 101.INS bota-20130930.xml EX-101.INS 281979
5 EXHIBIT 101.SCH bota-20130930.xsd EX-101.SCH 26712
6 EXHIBIT 101.CAL bota-20130930_cal.xml EX-101.CAL 20498
7 EXHIBIT 101.DEF bota-20130930_def.xml EX-101.DEF 118087
8 EXHIBIT 101.LAB bota-20130930_lab.xml EX-101.LAB 176022
9 EXHIBIT 101.PRE bota-20130930_pre.xml EX-101.PRE 119819
Mailing Address 2500 NORTHWINDS PARKWAY, SUITE 100 ALPHARETTA 2Q 30009
Business Address 2500 NORTHWINDS PARKWAY, SUITE 100 ALPHARETTA 2Q 30009 301-770-3099
Biota Pharmaceuticals, Inc. (Filer) CIK: 0000072444 (see all company filings)

EIN.: 591212264 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-35285 | Film No.: 131205934
SIC: 2836 Biological Products, (No Diagnostic Substances)